FGL(l) peptide is also known as:
- Fibroblast growth factor-like peptide 1 (FGL-1)
- NCAM-derived peptide 1 (NDP-1)
- Epitalon
FGL(l) is a synthetic peptide that is derived from the naturally occurring neural cell adhesion molecule (NCAM). NCAM is a protein that is found on the surface of nerve cells (neurons) and glial cells (cells that support and protect neurons). NCAM plays a role in cell adhesion, cell signaling, and cell growth and development.
FGL(l) is a short peptide that contains 14 amino acids. It is derived from the second fibronectin type III (F3) module of NCAM. FGL(l) has been shown to activate the fibroblast growth factor receptor (FGFR), which is a receptor that is involved in cell growth, development, and repair.
FGL(l) is being investigated for a variety of potential therapeutic applications, including:
- Neurological disorders: FGL(l) has been shown to protect neurons from damage and promote neuronal growth and repair. This suggests that FGL(l) could be used to treat neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and spinal cord injury.
- Cancer: FGL(l) has been shown to inhibit the growth and spread of cancer cells. This suggests that FGL(l) could be used to treat cancer.
- Cardiovascular disease: FGL(l) has been shown to improve cardiovascular function and protect the heart from damage. This suggests that FGL(l) could be used to treat cardiovascular diseases such as heart failure and coronary artery disease.
- Wound healing: FGL(l) has been shown to accelerate wound healing. This suggests that FGL(l) could be used to treat wounds, such as diabetic foot ulcers and pressure sores.
- Cognitive function: FGL(l) has been shown to improve cognitive function in animal studies. This suggests that FGL(l) could be used to treat cognitive decline associated with aging and other conditions.
- Longevity: FGL(l) has been shown to extend lifespan in animal studies. This suggests that FGL(l) could be used to promote longevity in humans.
FGL(l) is still under development, but it has the potential to be a valuable therapeutic agent for a variety of conditions.
Here are some additional thoughts on the different names of FGL(l) peptide:
- Fibroblast growth factor-like peptide 1 (FGL-1): This name is based on the fact that FGL(l) has been shown to activate the fibroblast growth factor receptor (FGFR).
- NCAM-derived peptide 1 (NDP-1): This name is based on the fact that FGL(l) is derived from the neural cell adhesion molecule (NCAM).
- Epitalon: This name is based on the fact that FGL(l) has been shown to extend lifespan in animal studies.
It is important to note that the name FGL(l) is the most commonly used name for this peptide. The other names, FGL-1, NDP-1, and Epitalon, are less commonly used.
If you are interested in learning more about FGL(l) peptide, I recommend that you talk to your doctor. Your doctor can help you to understand the potential benefits and risks of FGL(l) peptide and can determine whether it is right for you.
